- Home
- EQR vs DXCM Comparison
EQR vs DXCM Comparison
Compare EQR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- DXCM
- Stock Information
- Founded
- EQR 1993
- DXCM 1999
- Country
- EQR United States
- DXCM United States
- Employees
- EQR N/A
- DXCM N/A
- Industry
- EQR Real Estate Investment Trusts
- DXCM Medical/Dental Instruments
- Sector
- EQR Real Estate
- DXCM Health Care
- Exchange
- EQR Nasdaq
- DXCM Nasdaq
- Market Cap
- EQR 26.7B
- DXCM 34.1B
- IPO Year
- EQR 1993
- DXCM 2005
- Fundamental
- Price
- EQR $66.78
- DXCM $86.06
- Analyst Decision
- EQR Buy
- DXCM Strong Buy
- Analyst Count
- EQR 15
- DXCM 20
- Target Price
- EQR $79.00
- DXCM $98.50
- AVG Volume (30 Days)
- EQR 1.9M
- DXCM 3.5M
- Earning Date
- EQR 07-28-2025
- DXCM 07-24-2025
- Dividend Yield
- EQR 4.11%
- DXCM N/A
- EPS Growth
- EQR 8.50
- DXCM N/A
- EPS
- EQR 2.62
- DXCM 1.33
- Revenue
- EQR $3,010,100,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- EQR $5.13
- DXCM $16.74
- Revenue Next Year
- EQR $4.28
- DXCM $15.29
- P/E Ratio
- EQR $25.74
- DXCM $65.59
- Revenue Growth
- EQR 3.81
- DXCM 9.11
- 52 Week Low
- EQR $59.41
- DXCM $57.52
- 52 Week High
- EQR $78.84
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- EQR 34.93
- DXCM 54.82
- Support Level
- EQR $65.19
- DXCM $77.81
- Resistance Level
- EQR $69.87
- DXCM $88.32
- Average True Range (ATR)
- EQR 1.21
- DXCM 2.56
- MACD
- EQR -0.36
- DXCM -0.13
- Stochastic Oscillator
- EQR 15.54
- DXCM 68.79
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.